Skip to main content
Log in

Optimization of the Water-Insoluble Procedures for USP General Chapter Residual Solvents <467>

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The water-insoluble procedures in US Pharmacopeia (USP) General Chapter Residual Solvents <467>, which are based on European Pharmacopoeia procedures, were optimized and modified before their inclusion in the chapter to improve their scope, performance, and ruggedness. The optimized procedures use a static headspace introduction system with a gas chromatograph equipped with a flame ionization detector. This article describes some of the key changes made to the USP published procedures, including use of dimethyl sulfoxide (DMSO) or dimethylformamide (DMF) as the solvent, addition of 5 mL of water and 1 mL of sample (dissolved in DMSO or DMF) to the headspace vial, use of a 3:1 GC split ratio, and use of new matrix-matched system suitability solutions. These procedures were verified with two different active pharmaceutical ingredients—hydroxyzine pamoate and prednisone. In the investigation, the more polar material (hydroxyzine pamoate) showed greater recoveries for the optimized procedures when prepared in DMSO. The less polar material (prednisone) typically had greater recoveries in DMF for the optimized procedures. During experimentation, insights into sample preparation, additional types of headspace instrumentation, solvent purity, and other parameters were also gained.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. USP. US Pharmacopeia 32–National Formulary 27, Residual Solvents <467>, Supplement 1. Rockville, MD: USP; 2009:3948.

  2. USP. US Pharmacopeia 22–National Formulary 17, Organic Volatile Impurities <467>, Supplement 3. Rockville, MD: USP; 1990:2395.

  3. ICH. Harmonised Tripartite Guideline Q3C(R3), Impurities: Guideline for Residual Solvents. 1997. www.ich.org/LOB/Media/MEDIA423.pdf. Accessed 04 May 2010.

  4. EMEA. European Pharmacopeia, 5.4 Residual Solvents. Strasbourg: EMEA; 2009:50400.

    Google Scholar 

  5. EMEA. European Pharmacopeia, 2.4.24 Identification and Control of Residual Solvents. Strasbourg: EMEA; 2009:20424.

    Google Scholar 

  6. USP. US Pharmacopeia 32–National Formulary 27, General Notices and Requirements Section 5.60.20, Supplement 1. Rockville, MD: USP; 2009:6.

  7. FDA. Guidance for Industry: Residual Solvents in Drug Products Marketed in the United States. 2008. http://www.fda.gov/OHRMS/DOCKETS/98fr/FDA-2008-D-0413-gdl.pdf. Accessed 04 May 2010.

  8. Skoog DA, West DM, Holler FJ. Fundamentals of analytical chemistry. 5th ed. Philadelphia: Saunders College; 1988.

    Google Scholar 

  9. Schmidt TC. Analysis of methyl tert-butyl ether (MTBE) and tert-butyl alcohol (TBA) in ground and surface water. Trends Anal Chem. 2003;22:776–84.

    Article  CAS  Google Scholar 

  10. USP. Residual Solvents <467> Pharm Forum. 2006;32(2):277–86.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jennifer L. Belsky.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Belsky, J.L., Ashley, A.J., Bhatt, P.A. et al. Optimization of the Water-Insoluble Procedures for USP General Chapter Residual Solvents <467>. AAPS PharmSciTech 11, 994–1004 (2010). https://doi.org/10.1208/s12249-010-9460-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-010-9460-6

KEY WORDS

Navigation